NewswireToday - /newswire/ -
Arlington, VA, United States, 2009/02/03 - BioInformant, a specialized market research firm serving the life science industry, announces the publication of its latest report, "Stem Cell Research Products: Opportunities, Tools & Technologies" - BioInformant.com.
An analysis combining technology-derived market data with end-user statistical survey findings, this report explores current market conditions and provides guidance to companies developing a strategically positioned stem cell product line.
"A more in-depth understanding of the needs of scientists studying stem cells is of growing importance as the field becomes more complex and funding sources become harder to obtain," observed Dr. Douglas Jactern, Head of Research & Analysis for BioInformant.
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including: embryonic, fetal, adult, cord blood, cancer, and animal stem cells. Of interest to researchers, is the potential for use stem cells in regenerative medicine to treat conditions ranging from diabetes, to cardiovascular disease and neurological disorders. Also, the ability to use stem cells to improve drug target validation and toxicology screening is of intense interest to pharmaceutical companies. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.
To facilitate this research, a vast stem cells research products market is emerging. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific, Millipore, and Stem Cell Technologies, Products offered by these companies include: antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA and RNA-based characterization of stem cells, stem cell culture and media reagents, stem cell specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.
This market report includes:
• An overview of research applications, including shared priorities and priorities by segment;
• A breakdown of stem cell product categories;
• Market assessment, including grant rates, patent assessment, and publication rate analysis;
• Overview of funding sources, trends, and dollar values (both domestic and international);
• Market size valuations;
• Historical and future growth projections for the stem cell research products market;
• Competitive analysis of research tool suppliers;
• Communications strategies for accessing the marketplace;
• Suggestions for novel stem cells research products, And more
"Stem Cell Research Products: Opportunities, Tools & Technologies" was produced using proprietary technology-derived data, a 64-question online survey conducted by BioInformant, and insights provided by BioInformant’s team of Market Analysts. Over 400 chemists and biologists from North America, Europe, and Asia completed participated in the end-user survey.
BioInformant (bioinformant.com) is a specialized market research firm serving the life science industry. By leveraging proprietary methods for data collection, end-user surveys, and a trained staff of market analysts, we support companies interested in making more educated business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, measuring customer preferences, and evaluating brand strength and positioning.